• News

"FDA Approves Eczema Drug For Teens" - Dr. Max Gomez

  • CBS New York
  • New York, NY
  • (March 13, 2019)

The FDA has approved a drug for adolescents with eczema; it previously had only been available to adults. Eczema, or atopic dermatitis, is a huge problem. More than 30 million people in the U.S. have some form of it, including almost ten million children. Two years ago, the FDA approved an injectable drug called Dupixent to treat moderate to severe eczema in adults. Now, the FDA has approved Dupixent for adolescents ages 12-17. “It has changed their life. They’re no longer homeschooled, and they’re getting into college,” said Emma Guttman-Yassky, MD, PhD, director of the Center for Excellence in Eczema at the Icahn School of Medicine at Mount Sinai, who led the trials that got Dupixant approved for adolescents. She is hopeful there will soon be relief for young children with those more severe cases of eczema.

— Emma Guttman-Yassky, MD, PhD, Professor, Dermatology, Clinical Immunology, Medicine, Vice Chair, Research, Department of Dermatology, Director, The Center for Excellence in Eczema, Director, Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai

Learn more

Additional coverage: The Dermatologist; Healio: Infectious Diseases in Children; Medscape; MD Alert;BioPharma DiveBioSpace